Sylvia Lawry Centre for MS Research e.V. - The Human Motion Institute
Scientific Director: Martin Daumer PhD
Hohenlindener Str. 1
Tel: +49 89 2060 269 50
Fax: +49 89 2060 269 51
Legal Notice All informations contained in this web site are published and maintained by Sylvia Lawry Centre - The Human Motion Institute with due diligence. Data may become subject to changes. Therefore, Sylvia Lawry Centre - The Human Motion Institute does not assume any liability or guarantee for the timeliness, accuracy and completeness of the information provided.
Copyright All materials on this site are protected by copyright. Reproduction of information, data content, pictures or graphics requires the prior approval of Sylvia Lawry Centre - The Human Motion Institute.
Links This website may contain external links to other websites. Sylvia Lawry Centre - The Human Motion Institute is not responsible for the content of any website linked to or from this site. Sylvia Lawry Centre - The Human Motion Institute disclaims all warranties, as to the accuracy, legality, reliability, or validity of any content on any other website.
Regulatory European Medicines Agency (EMA) The SLCMSR has been shortlisted as a potential contractor of the EMA for Lots 1,2,3 and 4. Valid until 02. April 2015 1. Comparative reviews of drug utilisation patterns 2. Observational studies (electronic healthcare and other databases) 3. Observational safety or benefit:risk studies (primary data collection) 4. Systematic reviews or meta-analysis Food and Drug Administration (FDA) Letter of Intent: FDA 124858 FDA Response (accepted): FDA 124846 Briefing Book for EMA Qualification: FDA 124857 DDT COA #000105: actibelt in Sarcopenia: FDA Drug Development Tool Qualification Programs DDT COA #000106: actibelt in Multiple Sclerosis: actibelt DDT COA 000106
European Network of Centres for Pharmacoepidemiology and Pharmacovigilance (ENCePP) We are a partner centre of the ENCePP scientific network which is coordinated by the European Medicines Agency. We are dedicated to excellence in research by adhering to the ENCePP Guide on Methodological Standards and promoting scientific independence and transparency. We register studies in the ENCePP E-Register of Studies, a publicly accessible resource for the registration of pharmacoepidemiological and pharmacovigilance studies. SLCMSR is member of the workgroup "Pregnancy" of ENCePP.